Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
Endocrine-Related Cancer|February 22, 2023
Progress and challenges in experimental models for pheochromocytoma and paragangliomaArthur S Tischler, Judith FavierMedecine Sciences : M/S|July 19, 2012
[Genetics of paragangliomas and pheochromocytomas]Judith Favier, Anne-Paule Gimenez-RoqueploAnnales D'Endocrinologie|May 8, 2025
Altitude and paragangliomaJulie Sanceau, Rebecca Westbrook, Judith FavierBest Practice & Research. Clinical Endocrinology & Metabolism|December 1, 2010
Pheochromocytomas: the (pseudo)-hypoxia hypothesisJudith Favier, Anne-Paule Gimenez-RoqueploJournal of Cellular Biochemistry|February 16, 2006
Role of MSK1 in the signaling pathway leading to VEGF-mediated PAF synthesis in endothelial cellsCatherine Marchand, Judith Favier, Martin G SiroisEndocrine-Related Cancer|October 28, 2020
Epigenetic and metabolic reprogramming of SDH-deficient paragangliomasSophie Moog, Charlotte Lussey-Lepoutre, Judith FavierAnnales De Pathologie|March 9, 2020
[Pathologist contribution in the diagnosis of hereditary predisposition to paranganglioma and pheochromocytoma]Chloé Broudin, Judith Favier, Virginie Verkarre, et al.Nature Reviews. Endocrinology|November 12, 2014
Paraganglioma and phaeochromocytoma: from genetics to personalized medicineJudith Favier, Laurence Amar, Anne-Paule Gimenez-RoqueploBMC Cancer|July 28, 2007
HIF2 alpha reduces growth rate but promotes angiogenesis in a mouse model of neuroblastomaJudith Favier, Stéphanie Lapointe, Ricardo Maliba, et al.Pageof 11